The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells.
Dörfel D, Lechner CJ, Joas S, Funk T, Gutknecht M, Salih J, Geiger J, Kropp KN, Maurer S, Müller MR, Kopp HG, Salih HR, Grünebach F, Rittig SM.
Dörfel D, et al. Among authors: grunebach f.
Cancer Immunol Immunother. 2018 May;67(5):775-783. doi: 10.1007/s00262-018-2129-9. Epub 2018 Feb 21.
Cancer Immunol Immunother. 2018.
PMID: 29468363
Free PMC article.